First Tracks Biotherapeutics Inc (TRAX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.2x

Market Cap

$1.45B

MomentumView details →

1D Return

−4.82%

YTD Return

—

RSI (14)

46.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.2x

Market Cap

$1.45B

RSI (14)

46.8

MomentumView details →

1D Return

−4.82%

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−98.40%

ROA (TTM)

−90.69%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.95

EPS Surprise

−28.38%

Beats (12Q)

0/12

Next Q EPS Est

−$0.90

Avg Surprise (4Q)

−28.38%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

14.28x

Quick Ratio

14.28x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

First Tracks Biotherapeutics Inc reported its second-quarter financial results on Wednesday, showing a narrower loss compared to the prior year.22d ago

Similar companies

KalVista Pharmaceuticals, Inc.KALV Alumis Inc. Common StockALMS Maze Therapeutics, Inc.MAZE Immatics N.V.IMTX Replimune Group, Inc.REPL Vor Biopharma Inc.VOR Find similar companies →

Latest newsMore news →

First Tracks Biotherapeutics Inc reported its second-quarter financial results on Wednesday, showing a narrower loss compared to the prior year.22d ago